Horse complement protein C9: Primary structure and cytotoxic activity

Molecular Immunology

Volumn 33, Issue 7-8, 1996, Pages 725-733

  Esser, Alfred F ^a   Tarnuzzer, Roy W ^e   Tomlinson, Stephen ^c   Tatar, Laura D ^a   Stanley, Keith K ^b,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d HEART RESEARCH INSTITUTE   (Australia)

^e NONE

Author keywords

bacteriolysis; bovine C9; cDNA; hemolysis; horse serum

Indexed keywords

COMPLEMENT COMPONENT C9;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIOLYSIS; COMPLEMENT DEPENDENT CYTOTOXICITY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HEMOLYSIS; HORSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

BACTERIA (MICROORGANISMS); BOVINAE; EQUUS CABALLUS; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0030151997     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(96)00007-7     Document Type: Article

References (39)

1. Assis A. I., Pereira G., Azzolini A.E.C.S. and Barbosa J. E. (1991) Effect of the in vitro ageing on the restriction of sheep erythrocyte lysis by horse serum. Scand. J. Immun. 33, 579-594.
2. Bork P. and Bairoch A. (1995) Extracellular protein modules: a proposed nomenclature. (Poster Insert). TIBS 20.
3. Bhakdi S. and Tranum-Jensen J. (1986) C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly(C9) formation generates a stable transmembrane pore. J. Immun. 136, 2999-3005.
4. Blau K. A., Ward A. C. S., Prieur D. J. and Corbeil L. B. (1985) Serum susceptibility of bovine pasteurellas. Can. J. vet. Res. 51, 157-161.
5. Dankert J. R. and Esser A. F. (1987) Bacterial killing by complement: C9-mediated killing in the absence of C5b-8. Biochem. J. 244, 393-399.
6. DiScipio R. G. and Hugh T. E. (1985) The architecture of complement component C9 and poly(C9). J. biol. Chem. 260, 14802-14809.
7. Esser A. F. (1982) Interactions between complement proteins and biological and model membranes. In Biological Membranes, vol. 4 (Edited by Chapman D.) p. 277. Academic Press, London.
8. Esser A. F. (1990) The membrane attack pathway of complement. Year Immun. 6, 229-244.
9. Esser A. F., Tarnuzzer R. W., Tomlinson S. and Stanley K. K. (1991) c-DNA sequence of horse C9 and hemolytic activity. Complement Inflamm. 8, 146 (Abstract no. 61).
10. Esser A. F. (1991) Big MAC attack: complement proteins cause leaky patches. Immun. Today 12, 316-318.
11. Esser A. F. and Sodetz J. M. (1988) Membrane attack complex proteins C5b-6, C7, C8 and C9 of human complement. Meth. Enzymol. 162, 551-578.
12. Gubler U. and Huffman B. (1983) A simple and very efficient method for generating cDNA libraries. Gene 25, 263-268.
13. Harlow E. and Lane D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor, N.Y.
14. Houle J. J., Hoffmann E. M. and Esser A. F. (1988) Restriction of cell lysis by homologous complement: an analysis of membrane attack complex formation on target membranes. Blood 71, 280-286.
15. Houle J. J. and Hoffmann E. M. (1984) Evidence for restriction of the ability of complement to lyse homologous erythrocytes. J. Immun. 133, 1444-1452.
16. Inoue K. (1972) Immune bacteriolytic and bactericidal reactions. Res. Immunochem. Immunobiol. 1, 177-222.
17. Ish C., Ong G. L., Desai N. and Mattes M. J. (1993) The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species. Scand. J. Immun. 38, 113-122.
18. Kubens B. S. and Opferkuch W. (1988) Studies on serum resistance in Escherichia coli. Zbl. Bakt. Hyg. A 270, 52-65.
19. Lachmann P. J. (1989) The control of homologous lysis. Immun. Today 12, 312-315.
20. Lachmann P. J., Bowyer D. E., Nicol P., Dawson R. M. C. and Munn E. A. (1973) Studies on the terminal stages of complement lysis. Immunology 24, 135-145.
21. Laine R. O. and Esser A. F. (1989) Detection of refolding conformers of complement protein C9 during insertion into membranes. Nature 341, 63-65.
22. Lublin D. M. and Atkinson J. P. (1989) Decay-accelerating factor and membrane cofactor protein. Curr. Topics Microbiol. Immun. 153, 123-145.
23. MacKay S. L. D. and Dankert J. R. (1991) Bacterial killing and inhibition of inner membrane activity by C5b-9 complexes as a function of the sequential addition of C9 to C5b-8 sites. J. Immun. 145, 3367-3371.
24. Maniatis T., Fritsch E. F. and Sambrock J. (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, N.Y.
25. McCloskey M. A., Dankert J. R. and Esser A. F. (1989) Assembly of complement components C5b-8 and C5b-9 on lipid bilayer membranes: visualization by freeze-etch electron microscopy. Biochemistry 28, 534-540.
26. Mayer M. M. (1982) Membrane attack by complement (with comments on cell-mediated cytotoxicity). In Mechanisms of Cell mediated Cytotoxicity (Edited by Clark J. and Goldstein J.), p. 193. Plenum Publishing Corporation, New York, N.Y.
27. Peitsch M. C., Amiguet P., Guy R., Brunner J., Maizel J. V. and Tschopp J. (1990) Localization and molecular modelling of the membrane inserted domain of the ninth component of human complement and perforin. Molec. Immun. 27, 589-602.
28. Rollins S. A., Zhao J., Ninomiya H. and Sims P. J. (1991) Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 with C5b-8 or C9 within C5b-9. J. Immun. 146, 2345-2351.
29. Sanger F., Coulson A. R., Barrel B. G., Smith A. J. H. and Roe B. A. (1980) Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J. molec. Biol. 143, 161-178.
30. Stanley K. and Luzio J. (1988) A family of killer proteins. Nature 334, 475-476.
31. Stolfi R. L. (1968) Immune lytic transformation: a state of irreversible damage generated as a result of reaction of the eights component in the guinea pig complement system. J. Immun. 100, 46-54.
32. Taylor P. W. and Robinson M. K. (1980) Determinants that increase the serum resistance of Escherichia coli. Infect. Immun. 29, 278-280.
33. Taylor P. W. and Kroll H.-P. (1983) Killing of an encapsulated strain of Escherichia coli by human serum. Infect. Immun. 39, 122-131.
34. Taylor P. W. and Kroll H.-P. (1984) Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Molec. Immun. 21, 609-620.
35. Taylor P. W. (1992) Complement-mediated killing of susceptible Gram-negative bacteria: an elusive mechanism. Exp. clin. Immunogenet. 9, 48-56.
36. Tomlinson S., Stanley K. K. and Esser A. F. (1993) Domain structure, functional activity and polymerization of trout complement protein C9. Dev. comp. Immun. 17, 67-76.
37. Tomlinson S., Wang Y., Ueda E. and Esser A. F. (1995) Chimeric horse/human recombinant C9 proteins identify the amino acid sequence in horse C9 responsible for restriction of hemolysis. J. Immun. 155, 436-444.
38. Wang Y. and Esser A. F. (1993) Elimination of N-glycosylation sites in recombinant human complement protein C9 has no effect on hemolytic activity. FASEB J. 7, A1192.
39. Yarnall D. P. and Boyle M. D. P. (1986) Restriction of the lytic efficiency of complement on different erythrocyte targets: a re-examination of the activities of horse C8 and C9. Molec. Immun. 23, 823-829.